New procedure aims to zap nerves to fix slow heartbeat
NCT ID NCT07468383
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study tests a procedure called cardioneuroablation for people with a slow heart rate (bradycardia) caused by overactive vagal nerves. Doctors use a catheter to ablate (destroy) specific nerve clusters in the heart. The trial will enroll 188 participants aged 18-65 and measure changes in average heart rate and quality of life. The goal is to see if this can reduce symptoms like dizziness and fatigue without needing a pacemaker.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
cardioneuroablation (catheter procedure to ablate cardiac nerve clusters)
What this could lead to
If successful, this procedure could offer a non-drug, non-pacemaker option to control symptoms of slow heart rate caused by overactive vagal nerve activity.
What could go wrong
This is an early-stage study with no phase designation, so results are uncertain. The procedure is invasive and carries risks like bleeding, infection, or heart rhythm issues.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for AUTONOMIC NERVOUS SYSTEM DISEASES are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Beijing Anzhen Hospital, Capital Medical University
RECRUITINGBeijing, China, 100029, China
Contact Phone: •••-•••-•••• Email: •••••@•••••
Contact